Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02323698 · ClinicalTrials.gov registry record · Phase 1
Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury
A Phase 1 study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT02323698 is a Phase 1 study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 36 participants.
The verdict
NCT02323698, a Phase 1 study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
Accumulating evidence suggests that repeatedly breathing low oxygen levels for brief periods (termed intermittent hypoxia) is a safe and effective treatment strategy to promote meaningful functional recovery in persons with chronic spinal cord injury (SCI). The goal of the study is to understand how caffeine may augment the effects of intermittent hypoxia on motor function and spinal plasticity (ability of the nervous system to strengthen neural pathways based on new experiences) following SCI.
Interventions
- OTHER Placebo
- DRUG Caffeine
- OTHER AIH
- OTHER SHAM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2022-02-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02323698
The ClinicalTrials.gov registry entry for NCT02323698 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02323698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02323698 about?
NCT02323698 is a clinical study titled "Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury". Accumulating evidence suggests that repeatedly breathing low oxygen levels for brief periods (termed intermittent hypoxia) is a safe and effective treatment strategy to promote meaningful functional recovery in persons with chronic spinal cord injury (SCI). The goal of the study is to understand how...
What is the current status of trial NCT02323698?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2019-01-01. Estimated completion is 2022-02-19.
What interventions are being tested in trial NCT02323698?
The interventions under investigation include: Placebo (OTHER), Caffeine (DRUG), AIH (OTHER), SHAM (OTHER).
Who is sponsoring clinical trial NCT02323698?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.